Inventor · disambiguated record
Victor J. Hruby
Also filed as: HRUBY VICTOR · HRUBY VICTOR J
39 granted patents·10 pending applications·1,156 citations·filing 1981–2024
98Inventor score
Files withUNIV ARIZONA26H LEE MOFFITT CANCER CT & RES5UNIVERSITY PATENTS INC5COMPETITIVE TECH INC3ARIZONA TECH DEV2
Top patents by PatentIndex Score
49 records- 0197US5731408APeptides having potent antagonist and agonist bioactivities at melanocortin receptorsUNIV ARIZONA·Filed 1995·Granted Mar 24, 1998·184 cites·3 claims
- 0295US4866038AMethod of stimulating integumental melanocytes by topical application of analogs of alpha-mshUNIVERSITY PATENTS INC·Filed 1988·Granted Sep 12, 1989·107 cites·21 claims
- 0394US5674839ACyclic analogs of alpha-MSH fragmentsCOMPETITIVE TECH INC·Filed 1994·Granted Oct 7, 1997·125 cites·18 claims
- 0494US4684620ACyclic polypeptides having mu-receptor specificityGIBSON STEPHENS NEUROPHARMACEU·Filed 1984·Granted Aug 4, 1987·203 cites·16 claims
- 0593US9814755B2Methods for the treatment of depression and anxietyUNIV ARIZONA·Filed 2015·Granted Nov 14, 2017·7 cites·18 claims
- 0692US5714576ALinear analogs of alpha-msh fragmentsCOMPETITIVE TECH INC·Filed 1997·Granted Feb 3, 1998·109 cites·35 claims
- 0790US9821023B2Methods for the treatment of central nervous system (CNS) disorders and mood disordersUNIV ARIZONA·Filed 2015·Granted Nov 21, 2017·7 cites·20 claims
- 0890US4485039ASynthetic analogues of α-melanotropinUNIVERSITY PATENTS INC·Filed 1982·Granted Nov 27, 1984·61 cites·8 claims
- 0987US4518711AConformationally constrained cyclic enkephalin analogs with delta receptor specificityGIBSON STEPHENS INST·Filed 1983·Granted May 21, 1985·41 cites·26 claims
- 1087US2025129118A1Melanocortin 1 receptor ligands and methods of useH LEE MOFFITT CANCER CT & RES·Filed 2024·Application pending·0 cites
- 1185US4918055AMethod of stimulating melanocytes by topical application of analogs of alpha-MSH, and compositions for use in sameHRUBY VICTOR J·Filed 1988·Granted Apr 17, 1990·43 cites·21 claims
- 1284US4457864ASynthetic analogues of α-melanotropinUNIVERSITY PATENTS INC·Filed 1981·Granted Jul 3, 1984·49 cites·3 claims
- 1382US9539301B2Melanotropin ligands for skin careUNIV ARIZONA·Filed 2016·Granted Jan 10, 2017·3 cites·19 claims
- 1482US4649191AConformationally constrained alpha-melanotropin analogs with specific central nervous system activityGIBSON STEPHENS NEUROPHARMACEU·Filed 1984·Granted Mar 10, 1987·41 cites·12 claims
- 1580US10617681B21-arylalkyl-4-acylaminopiperidine compoundsUNIV ARIZONA·Filed 2018·Granted Apr 14, 2020·1 cites·17 claims
- 1680US5683981ACyclic bridged analogs of α-MSH and methods thereofCOMPETITIVE TECH INC·Filed 1995·Granted Nov 4, 1997·53 cites·18 claims
- 1779US10766925B2Opioid receptor modulatorsUNIV ARIZONA·Filed 2017·Granted Sep 8, 2020·2 cites·20 claims
- 1878US12173087B2Melanocortin 1 receptor ligands and methods of useH LEE MOFFITT CANCER CT & RES·Filed 2022·Granted Dec 24, 2024·0 cites·18 claims
- 1978US9290539B2Melanotropin ligands for skin careUNIV ARIZONA STATE·Filed 2014·Granted Mar 22, 2016·3 cites·9 claims
- 2077US9765027B2Substituted 1-arylethyl-4-acylaminopiperidine derivatives as opioid/alpha-adrenoreceptor modulators and method of their preparationTHE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIV OF ARIZAONA·Filed 2015·Granted Sep 19, 2017·3 cites·11 claims
- 2176US5049547AComposition for stimulating integumental melanocytesUNIVERSITY PATENTS INC·Filed 1989·Granted Sep 17, 1991·52 cites·10 claims
- 2276US5017689ADynorphin analogs specific for kappa opioid receptorsARIZONA TECH DEV·Filed 1989·Granted May 21, 1991·22 cites·13 claims
- 2375US7816082B2Methods of identifying pancreatic cancer cellsUNIV ARIZONA STATE·Filed 2008·Granted Oct 19, 2010·4 cites·5 claims
- 2474US11230568B2Melanocortin 1 receptor ligands and methods of useH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Jan 25, 2022·0 cites·18 claims
- 2573US9441013B2Melanocortin 1 receptor ligands and methods of useGILLIES ROBERT J·Filed 2012·Granted Sep 13, 2016·2 cites·16 claims
- 2673US8026218B2Bifunctional analgesic compounds for opioid receptor agonists and neurokinin-1 receptor antagonistsUNIV ARIZONA·Filed 2007·Granted Sep 27, 2011·3 cites·43 claims
- 2769US11440885B2Substituted 1-arylalkyl-4-acylaminopiperidine compounds and methods of producing and using the sameUNIV ARIZONA·Filed 2020·Granted Sep 13, 2022·0 cites·17 claims
- 2866US11124542B2Modulators of melanocortin receptorsUNIV ARIZONA·Filed 2019·Granted Sep 21, 2021·0 cites·4 claims
- 2966US2018021322A11-arylalkyl-4-acylaminopiperidine compoundsUNIV ARIZONA·Filed 2017·Application pending·0 cites
- 3062US2018235949A1Substituted 1-Arylalkyl-4-Acylaminopiperidine Compounds and Methods of Producing and Using the SameUNIV ARIZONA·Filed 2016·Application pending·0 cites
- 3161US12440570B2Conjugation of MCR1 ligand with cytotoxic drugs for treating skin cancerUNIV ARIZONA·Filed 2022·Granted Oct 14, 2025·0 cites·16 claims
- 3259US10329326B2Melanocortin 1 receptor ligands and methods of useH LEE MOFFITT CANCER CT & RES·Filed 2016·Granted Jun 25, 2019·0 cites·8 claims
- 3351US2019177371A1Novel modulators of melanocortin receptorsUNIV ARIZONA·Filed 2019·Application pending·0 cites
- 3450US10653743B2Methods for the treatment of depression and anxiety by a melanocortin 5 receptor antagonist, PG-20NUNIV ARIZONA·Filed 2016·Granted May 19, 2020·0 cites·12 claims
- 3549US11542302B2Modulators of melanocortin receptors for the treatment of depression and anxietyUNIV ARIZONA·Filed 2020·Granted Jan 3, 2023·0 cites·18 claims
- 3649US10550157B2Compositions and methods for treating central nervous system (CNS) disorders and mood disordersUNIV ARIZONA·Filed 2016·Granted Feb 4, 2020·0 cites·8 claims
- 3748US11970521B2Neuroprotective beta amyloid core peptides and peptidomimetic derivativesUNIV ARIZONA·Filed 2017·Granted Apr 30, 2024·0 cites·16 claims
- 3847US2022024978A1Peptides comprising opioid receptor agonist and nk1 receptor antagonist activitiesUNIV ARIZONA·Filed 2021·Application pending·0 cites
- 3947US2021196782A1Multifunctional opioid receptor ligands and methods of treating painUNIV ARIZONA·Filed 2021·Application pending·0 cites
- 4047US2017022252A1Novel modulators of melanocortin receptorsUNIV ARIZONA·Filed 2015·Application pending·0 cites
- 4145US10428115B2Dynorphin A analogs with bradykinin receptors specificity for modulation of neuropathic painUNIV ARIZONA·Filed 2014·Granted Oct 1, 2019·0 cites·8 claims
- 4245US5631230AReceptor selective analogues of cholecystokinin-8ARIZONA TECH DEV·Filed 1994·Granted May 20, 1997·10 cites·8 claims
- 4345US5326751AEnkephalin analogsUNIV ARIZONA·Filed 1992·Granted Jul 5, 1994·15 cites·17 claims
- 4443US2016051704A1Molecular imaging probes for lung cancer intraoperative guidanceH LEE MOFFITT CANCER CT & RES·Filed 2015·Application pending·0 cites
- 4541US10188704B2Enhanced melanoma cancer prevention by novel melanotropinsUNIV ARIZONA·Filed 2016·Granted Jan 29, 2019·0 cites·20 claims
- 4638US2019255142A1Novel modulators of melanocortin receptors for the treatment of depression and anxietyUNIV ARIZONA·Filed 2016·Application pending·0 cites
- 4737US4430326AMethod of diminishing glucose levels resulting from endogenous glucagonUNIVERSITY PATENTS INC·Filed 1981·Granted Feb 7, 1984·6 cites·15 claims
- 4836US2018127465A1Multifunctional opioid receptor ligands and methods of treating painUNIV ARIZONA·Filed 2017·Application pending·0 cites
- 4934US11141452B2Bifunctional compounds for relief of pain comprising an opioid receptor agonist moiety and a NK1 receptor antagonist moiety and methods for treating painUNIV ARIZONA·Filed 2015·Granted Oct 12, 2021·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Victor J. Hruby files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →